Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease: Pathophysiological implications

European Heart Journal

Volumn 22, Issue 17, 2001, Pages 1572-1577

  Monaco, C ^a   Crea, Filippo ^a   Niccoli, G ^a   Summaria, F ^a   Cianflone, D ^a   Bordone, R ^b   Bellomo, G ^b   Maseri, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Antibodies; Coronary artery disease; Inflammation; Lipoproteins; Peripheral artery disease

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; COPPER SULFATE; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXIDASE;

ADULT; AGED; ANGINA PECTORIS; ANTIBODY TITER; ARTERY OCCLUSION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; AUTOIMMUNITY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; ARTERIOSCLEROSIS; AUTOANTIBODIES; C-REACTIVE PROTEIN; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES;

EID: 0034878191     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2554     Document Type: Article

References (39)

1. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease
2. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes
3. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction
4. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia
5. Acute T-cell activation is detectable in unstable angina
6. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes
7. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
8. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury
9. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina
10. Episodic activation of the coagulation system in unstable angina does not elicit an acute phase reaction
11. Cytomegalovirus replication is not a cause of instability in unstable angina
12. Association of virulent Helicobacter pylori strains with ischemic heart disease
13. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
14. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study
15. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study
16. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease
17. Autoantibody against oxidised LDL and progression of carotid atherosclerosis
18. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk
19. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low density lipoproteins
20. Antioxidants atherosclerotic heart disease
21. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit
22. Low density lipoprotein undergoes oxidative modification in vivo
23. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
24. Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation
25. Immunological and functional properties of in vitro oxidized low density lipoprotein
26. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: A biochemical signature of an enhanced in vivo low-density lipoprotein oxidation
27. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease
28. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis
29. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study
30. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL
31. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein
32. Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis
33. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate
34. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity
35. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis
36. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits
37. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris
38. Inflammation, atherosclerosis and ischemic events - Exploring the hidden side of the moon
39. Different thrombotic and inflammatory patterns between unstable angina and peripheral vascular disease